 SOUTH SAN FRANCISCO, Calif., April 27, 2022 GLOBE NEWSWIRE -- Aligos Therapeutics, Inc. Nasdaq: ALGS, a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it will report the companys first quarter 2022 financial results on Wednesday, May 4, 2022 after the close of U.S. financial markets. 